West Nile Virus: What Clinicians Need to Recognize, Test, and Report During the Summer Surge

Most summers, West Nile virus barely comes up outside infectious disease circles and local health department bulletins. Not this year. National case counts are climbing faster than they have in over two decades, Arizona has already reported multiple deaths, and states that don't usually see much activity this early are confirming human cases well ahead of schedule.

For a lot of clinicians, West Nile virus sits somewhere in the back of the mind, a rare cause of summer fever you might consider if a patient happens to mention a mosquito bite. This season, it deserves to move a lot closer to the front of your thinking, especially for anyone walking in with unexplained fever, headache, or neurologic symptoms between now and October.

So let's get into it. What's actually driving this season, how to recognize the disease clinically, when to test and how, the ICD-10 and CPT details that keep your documentation and billing clean, and what providers generally need to know about reporting a case, wherever you happen to be practicing.

Why 2026 Is Shaping Up to Be an Unusually Active Season

The numbers make the case on their own. As of August 4, 2026, the CDC's ArboNET system had confirmed 143 human West Nile virus cases nationally, up from 113 just a week before that. That's a fast climb, and it's happening right as the country heads into the stretch of summer when transmission is typically at its worst.

Rewind a bit further and the early numbers look even more unusual against history. By June 30, the CDC had confirmed 48 cases spread across 23 states, nearly five times the historical average of roughly 10 cases at that same point in the year. Of those early cases, 38, about 80 percent, were neuroinvasive, meaning the virus had already reached the brain or spinal cord. That's a strikingly high share this early on, and it's probably telling us something about how surveillance works more than anything else. It tends to catch the sickest patients first, since people with mild symptoms rarely bother getting tested.

Arizona has been the center of it so far. Maricopa County alone had 29 confirmed cases and five deaths by early July. Texas, Colorado, Tennessee, California, and Oklahoma have all reported human cases as the season has gone on. If you want a sense of scale, Johns Hopkins researchers pointed out that in 2003, the worst West Nile outbreak the U.S. has ever recorded, only 44 cases had shown up nationally by the end of July. That season ended with close to 10,000 cases and 264 deaths.

That doesn't mean 2026 is going to hit those numbers. But it does mean this season started earlier and harder than anything in recent memory, and it's worth remembering that confirmed cases represent only a slice of the real picture. CDC officials have said the true infection count could be 30 times higher than what shows up in surveillance data, since most people never get sick enough to be tested in the first place.

What West Nile Virus Looks Like in Your Exam Room

Here's the tricky part clinically. Most people infected with West Nile virus never walk into your office at all. About 80 percent of infections cause no symptoms whatsoever. Of the remaining 20 percent, most get what's commonly called West Nile fever, a self-limited illness with fever, headache, body aches, and sometimes a rash or swollen lymph nodes that can drag on for days or occasionally weeks.

The presentation that actually matters most is neuroinvasive disease. It shows up in under 1 percent of infections, but when it happens, it's serious. This is where the virus gets into the central nervous system and causes meningitis, encephalitis, or, less commonly, acute flaccid paralysis that can look a lot like Guillain-Barré syndrome or polio at first glance.

If a patient comes in during mosquito season with fever plus any of the following, West Nile virus should genuinely be on your list, not just something you think of after ruling everything else out:

1. New headache with neck stiffness or light sensitivity
2. Confusion or altered mental status that feels out of proportion to the fever itself
3. New weakness, especially if it's asymmetric
4. An acute tremor or myoclonus that came on suddenly
5. A febrile illness that just isn't resolving the way a typical summer virus would

None of this is specific to West Nile virus by itself, and that's the honest challenge. Enteroviral meningitis, other arboviruses, even early bacterial meningitis can present similarly at first. That's exactly why a solid exposure history matters as much as the exam findings. Ask about outdoor activity, recent mosquito bites, and where the patient's been. It's often the detail that points you in the right direction.

Who Is Actually at Risk for Severe Disease

Age is the biggest single risk factor for progressing to severe disease. People over 60, and especially over 70, face meaningfully higher risk, and it keeps climbing with each decade. Public health guidance across the country consistently flags people over 50 and anyone immunocompromised as the groups most likely to get seriously sick.

A few other things worth keeping in mind:

1. Solid organ transplant recipients and other immunocompromised patients face higher risk
2. Diabetes and hypertension have both been linked to worse outcomes in several studies
3. A history of alcohol use disorder has also been associated with higher risk of neuroinvasive disease
4. Rare transmission routes exist too, blood transfusion, organ transplant, and mother-to-fetus transmission, worth keeping in the back of your mind for patients without an obvious mosquito exposure

Healthy patients under 60 without these risk factors will mostly have mild, self-limiting illness. That's not a reason to dismiss West Nile virus in younger patients entirely, but your suspicion for the neuroinvasive form should rise quite a bit as age and comorbidity go up.

Ordering the Right Test at the Right Time

Timing matters more here than most clinicians expect, and getting it wrong is probably the single most common reason for a falsely reassuring result or an unnecessary repeat test down the line.

Serology, IgM and IgG antibody testing, is the standard first-line test, billed under CPT 86788 for IgM and 86789 for IgG. IgM antibodies usually don't show up until three to eight days after symptoms start, so testing on day one or two can easily give you a false negative. Once IgM does appear, it tends to stick around for 30 to 90 days, sometimes much longer, which means a positive result doesn't automatically confirm the current illness is the acute infection. That matters especially in areas with ongoing transmission, where a patient could have been exposed earlier in the season without knowing it.

Cerebrospinal fluid antibody testing becomes the right move when neuroinvasive disease is a real concern. A lumbar puncture showing lymphocytic pleocytosis with elevated protein fits viral meningoencephalitis, and CSF IgM testing adds real diagnostic specificity for West Nile virus. Any patient with encephalitis or meningitis features during mosquito season, without a clearer explanation on the table, is a reasonable candidate for this.

PCR testing has a narrower window where it's actually useful. Viremia tends to be brief and often clears before a patient is sick enough to seek care, so PCR works best early in illness or in immunocompromised patients who may stay viremic longer. Later in the clinical course, it's a less reliable way to rule things out.

The practical point here: if a patient is early in their illness and your suspicion is high, a negative serology result on day one or two shouldn't be the end of the story. Repeat testing on convalescent serum, or CSF testing if neurologic symptoms show up, is often what actually gets you to a confirmed diagnosis.

Coding West Nile Virus Correctly

This is where solid clinical work sometimes runs into completely avoidable denial trouble, mostly because the ICD-10 coding here is more specific than a lot of providers realize.

The relevant codes sit under category A92.3.

A92.30 covers unspecified West Nile virus infection, meaning uncomplicated illness without documented neurologic involvement. A92.31 is specifically for encephalitis. A92.32 covers other neurologic manifestations, things like meningitis or acute flaccid paralysis that don't technically meet the definition of encephalitis. A92.39 covers other complications.

Here's the mistake billing teams see constantly. A provider documents clear neurologic findings, confusion, meningismus, focal weakness, and then the claim goes out under the unspecified A92.30 code anyway, usually just because it's the code people remember. Payers reviewing the claim against the documentation will often catch that mismatch, and it can trigger a records request or a flat denial tied to medical necessity, particularly for inpatient care or advanced imaging billed alongside it.

The fix is simple in theory. Code to the highest level of specificity your documentation actually supports, and make sure the note itself spells out the neurologic finding driving that code, not just the lab result sitting next to it.

Reportable Disease Requirements: What Providers Need to Know

West Nile virus is a nationally notifiable condition, so every state requires providers and labs to report confirmed or suspected human cases to public health. What varies quite a bit is exactly how and when that reporting has to happen.

A few examples show how different this looks state to state. Washington requires healthcare providers and facilities to report cases to the local health jurisdiction within three business days, while labs have to report most positive results within two business days. Texas treats arboviral infections, the category West Nile virus falls under, as reportable statewide, with specific timeframes published by the Department of State Health Services. A number of states, Maryland among them, sort reportable conditions into either an immediate category or a within one working day category, and it isn't always obvious which one applies to a given arboviral case without checking that state's specific guidance directly.

Because these rules genuinely differ by jurisdiction, the safest bet is to know your own state's current requirements before the season gets busy, rather than trying to look them up mid-shift. If you're ever not sure which timeframe applies, especially for a neuroinvasive case, treat it as an immediate report and call your local or state health department. Those are exactly the cases where faster public health follow-up actually matters.

This whole reporting piece runs separately from your billing and coding workflow, but in practice the two feed off each other. A case that's documented well enough to clearly support the ICD-10 code you're billing is also a case that's easy to report accurately, since the same details, symptom onset, neurologic findings, lab confirmation, do double duty for both.

Common Mistakes That Slow Down Testing and Billing

A handful of patterns keep showing up in these cases, and most of them are easy enough to avoid once you know to watch for them.

Testing too early and stopping there is a common one. A negative IgM result on day one of illness doesn't rule anything out, but plenty of providers treat it that way and close the door on the diagnosis prematurely. If suspicion stays high, repeat testing later, or CSF testing if neurologic symptoms appear, is often what's actually needed.

Defaulting to the unspecified code out of habit is another. As covered above, this creates a mismatch between the documentation and the billed diagnosis that invites denials, particularly around hospitalization or advanced imaging.

Forgetting the reportable disease step entirely happens more than you'd think during a busy stretch. It's not a billing problem directly, but a missed or late report can create real compliance exposure for the practice.

Skipping the exposure history is another small thing that has outsized effects. A single sentence noting outdoor activity, recent mosquito bites, or known local transmission strengthens both the clinical picture and the medical necessity case for testing, especially anything that draws more payer scrutiny like CSF studies or hospitalization.

And assuming a positive IgM automatically confirms acute infection is a subtle trap. Since IgM can linger for months, a positive result in a patient with an unusual or drawn-out presentation might actually reflect a past infection, not the current one. That distinction matters clinically, and it can matter for documentation if a payer starts questioning whether the diagnosis code for the current encounter is really supported.

Actionable Steps for Your Practice This Summer

A few practical habits go a long way during a season like this one.

Set up something simple, even just a note in your EHR's seasonal alert system, that keeps West Nile virus on the radar as an active differential for febrile or neurologic presentations from roughly July through October. Make sure ordering clinicians actually know the IgM testing window, so a negative day-one result doesn't shut down the diagnostic question too soon. Keep your state and local health department's reporting contact somewhere easy to find, not buried in a binder nobody's opened since last year. And build the habit of connecting the specific neurologic finding to the ICD-10 code in the note itself, even one sentence does it, because that habit alone prevents a real chunk of downstream denials.

Expert Recommendations

If your practice, urgent care, or hospital is seeing more febrile and neurologic cases this summer, a few things are worth getting ahead of beyond the individual patient visit.

Talk to your lab about turnaround expectations for both serology and CSF testing, since a delay there can slow down clinical management and how quickly a reportable case actually reaches public health. If your organization sees enough infectious disease or neurology volume, it's worth a quick refresher for coding staff on the A92.3 family specifically. It's a low-volume area, but a single missed specificity requirement can hold a claim up for weeks. And no matter which state you're in, keep an eye on local surveillance updates. Spray notices and mosquito pool results tend to signal rising local risk before the human case counts catch up.

Frequently Asked Questions

1. How many West Nile virus cases have been confirmed in the U.S. in 2026?

As of August 4, 2026, the CDC's ArboNET system had confirmed 143 human cases nationally. That number is expected to keep climbing through August and September, the peak transmission months.

1. Which states have seen the most West Nile virus activity in 2026?

Arizona has reported the largest share by far, with Maricopa County as the epicenter. Texas, Colorado, Tennessee, California, and Oklahoma have all reported human cases as the season has progressed.

1. What are the early symptoms of West Nile virus?

Most infected people never develop symptoms at all. Those who do usually get fever, headache, body aches, and sometimes a rash or swollen lymph nodes. Symptoms can last a few days or stretch into several weeks.

1. What does neuroinvasive West Nile virus look like?

It shows up in under 1 percent of infections and includes encephalitis, meningitis, and acute flaccid paralysis. Watch for confusion, neck stiffness, focal weakness, or an acute movement disorder alongside fever.

1. When should a clinician order West Nile virus testing?

Consider it for anyone with fever plus neurologic symptoms during mosquito season, roughly July through October in most of the country. IgM testing is most reliable starting three to eight days after symptom onset, so very early testing can miss it.

1. What is the correct ICD-10 code for West Nile virus?

It depends on what's actually going on clinically. A92.30 is for unspecified infection with no documented neurologic involvement, A92.31 is for encephalitis specifically, A92.32 covers other neurologic manifestations like meningitis or paralysis, and A92.39 covers other complications. Code to whatever specificity your documentation actually supports.

1. What CPT codes are used for West Nile virus antibody testing?

IgM is billed under CPT 86788 and IgG under CPT 86789. They're commonly ordered together as an initial serology panel.

1. Is West Nile virus a reportable disease?

Yes, in every state. It's a nationally notifiable condition, and confirmed or suspected cases have to be reported to public health. The exact timeframe and process vary by state, so it's worth confirming the specifics for wherever you practice.

1. Who is at highest risk for severe West Nile virus disease?

People over 50, with risk climbing further with age, along with immunocompromised patients, organ transplant recipients, and those with diabetes or hypertension.

1. Is there a vaccine or specific treatment for West Nile virus?

No. There's no licensed vaccine or antiviral treatment for humans. Care is supportive, and for neuroinvasive disease, that usually means hospitalization for close monitoring and managing complications as they come up.